View in EDS

The utility of rat jejunal permeability for biopharmaceutics classification system.

Saved in:
Bibliographic Details
Title: The utility of rat jejunal permeability for biopharmaceutics classification system.
Authors: Zakeri-Milani, Parvin, Valizadeh, Hadi, Tajerzadeh, Hosnieh, Islambulchilar, Ziba
Source: Drug Development & Industrial Pharmacy; Dec2009, Vol. 35 Issue 12, p1496-1502, 7p, 3 Charts, 1 Graph
Subject Terms: BIOPHARMACEUTICS, LABORATORY rats, PHARMACY, MALABSORPTION syndromes, PHARMACOLOGY
Abstract: Purpose: The biopharmaceutical classification system has been developed to provide a scientific approach for classifying drug compounds based on their dose/solubility ratio and human intestinal permeability. Therefore in this study a new classification is presented, which is based on a correlation between rat and human intestinal permeability values. Methods: In situ technique in rat jejunum was used to determine the effective intestinal permeability of tested drugs. Then three dimensionless parameters—dose number, absorption number, and dissolution number ( Do, An, and Dn)—were calculated for each drug. Results: Four classes of drugs were defined, that is, class I, D0 < 0.5, Peff(rat) > 5.09 × 10−5 cm/s; class II, Do > 1, Peff(rat) > 5.09 × 10 −5 cm/s; class III, D0 < 0.5, Peff(rat) < 4.2 × 10−5 cm/s; and class IV, Do > 1, Peff(rat) < 4.2 × 10−5 cm/s. A region of borderline drugs (0.5 < Do < 1, 4.2 × 10−5 < Peff(rat) < 5.09 × 10−5 cm/s) was also defined. Conclusion: According to obtained results and proposed classification for drugs, it is concluded that drugs could be categorized correctly based on dose number and their intestinal permeability values in rat model using single-pass intestinal perfusion technique. This classification enables us to remark defined characteristics for intestinal absorption of all four classes using suitable cutoff points for both dose number and rat effective intestinal permeability values. [ABSTRACT FROM AUTHOR]
Copyright of Drug Development & Industrial Pharmacy is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Be the first to leave a comment!
You must be logged in first